Asymmetric synthesis of the milbemycin .beta.3 spiroketal subunit
摘要:
The milbemycin beta(3) spiroketal subunit 2 has been prepared with a high degree of enantiomeric purity. This represents the first reagent-controlled asymmetric synthesis of this complex molecule starting from an achiral starting material. Key reactions include Sharpless epoxidation, asymmetric hydroboration, and the Birch reduction of a meta-substituted cinnamyl epoxide. The enantiomeric excess of 2 was determined to be > 95% by a chiral shift H-1 NMR experiment with both optically active and racemic 2. The overall yield was 1.2% from methyl m-toluate (3).
Asymmetric synthesis of the milbemycin .beta.3 spiroketal subunit
摘要:
The milbemycin beta(3) spiroketal subunit 2 has been prepared with a high degree of enantiomeric purity. This represents the first reagent-controlled asymmetric synthesis of this complex molecule starting from an achiral starting material. Key reactions include Sharpless epoxidation, asymmetric hydroboration, and the Birch reduction of a meta-substituted cinnamyl epoxide. The enantiomeric excess of 2 was determined to be > 95% by a chiral shift H-1 NMR experiment with both optically active and racemic 2. The overall yield was 1.2% from methyl m-toluate (3).
Asymmetric synthesis of the milbemycin .beta.3 spiroketal subunit
作者:Mark A. Holoboski、Emil Koft
DOI:10.1021/jo00029a033
日期:1992.1
The milbemycin beta(3) spiroketal subunit 2 has been prepared with a high degree of enantiomeric purity. This represents the first reagent-controlled asymmetric synthesis of this complex molecule starting from an achiral starting material. Key reactions include Sharpless epoxidation, asymmetric hydroboration, and the Birch reduction of a meta-substituted cinnamyl epoxide. The enantiomeric excess of 2 was determined to be > 95% by a chiral shift H-1 NMR experiment with both optically active and racemic 2. The overall yield was 1.2% from methyl m-toluate (3).